Oxytocin receptor binding in rat and human heart

Canadian Journal of Cardiology

Volumn 15, Issue 11, 1999, Pages 1267-1273

  Cicutti, Nicholas J ^a   Smyth, Catherine E ^a   Rosaeg, Ola P ^a   Wilkinson, Michael ^b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c IWK HEALTH CENTRE   (Canada)

Author keywords

Hormones; Myocardium; Receptors

Indexed keywords

ATOSIBAN; HEART RECEPTOR; OXYTOCIN; OXYTOCIN DERIVATIVE; OXYTOCIN RECEPTOR; SEX HORMONE; VASOPRESSIN;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; FETUS; HEART; HEART LEFT VENTRICLE; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; NEWBORN; NONHUMAN; OVARIECTOMY; PREGNANCY; RADIOASSAY; RADIORECEPTOR ASSAY; RAT; RECEPTOR BINDING; RECEPTOR DENSITY;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; FEMALE; HEART ATRIA; HEART VENTRICLES; HUMANS; MYOCARDIUM; OVARIECTOMY; PREGNANCY; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OXYTOCIN; UTERUS;

EID: 0033452329     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hendricks CH, Brenner WE. Cardiovascular effects of oxytocic drugs used postpartum. Am J Obstet Gynecol 1972;108:751-60.
2. Andersen TW, DePadua CB, Stenger V, Prystowsky H. Cardiovascular effects of rapid intravenous injection of synthetic oxytocin during elective cesarean section. Clin Pharm Ther 1965;6:345-9.
3. Johnstone M. The cardiovascular effects of oxytocic drugs. Br J Anaesth 1972;44:826-33.
4. Weis FR, Markello R, Mo B, Bochiechio P. Cardiovascular effects of oxytocin. Obstet Gynecol 1975;46:211-4.
5. Nakano J, Fisher RD. Studies on the cardiovascular effects of synthetic oxytocin. J Pharmacol Exp Ther 1963;142:206-14.
6. Desiderio MA, Hanson KM. Splanchnic vascular effects of pharmacologic doses of oxytocin in the canine. Proc Soc Exp Biol Med 1981;166:432-7.
7. Tran LD, Montastruc JL, Montrastruc P. Effect of lysine-vasopressin and oxytocin on central cardiovascular regulation. Br J Pharmacol 1982;77:69-73.
8. Brooks DP, Share L, Crofton JI, Rockhold RW, Matsui K. Effect of vertebral artery infusions of oxytocin on plasma vasopressin concentration, plasma renin activity, blood pressure and heart rate and their response to hemorrhage. Neuroendocrinology 1984;38:382-6.
9. Chiu KW, Lee YC, Pang PKT. Neurohypophysial hormones and cardiac activity in the frog, Rana tigrina, and in the snake, Ptyas mucosa. Gen Comp Endocrinol 1990;78:150-4.
10. Chiu KW, Lee YC. Cardiac activity of some peptide hormones in the frog, Rana tigrina. Comp Biochem Physiol C 1992;103:483-7.
11. Aonuma S, Kohama Y, Akai K, et al. Effects of oxytocin on beating properties, myosin ATPase activity and macromolecular synthesis of rat myocardial cells in culture. Chem Pharm Bull (Tokyo) 1979;27:1857-63.
12. Favaretto ALV, Ballejo GO, Albuquerque-Araújo WIC, et al. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Peptides 1997;18:1377-81.
13. Krieg M, Smith K, Bartsch W. Demonstration of a specific androgen receptor in rat heart muscle: relationship between binding, metabolism, and tissue levels of androgens. Endocrinology 1978;103:1686-94.
14. Lin AL, Gonzalez R Jr, Shain SA. Androgen directs apparent cytoplasmic and nuclear distribution of rat cardiovascular androgen receptors. Arteriosclerosis 1985;5:659-67.
15. Lin AL, Shain SA. Estrogen-mediated cytoplasmic and nuclear distribution of rat cardiovascular estrogen receptors. Arteriosclerosis 1985;5:668-77.
16. Lin AL, Shain SA. Sexual dimorphism characterizes steroid hormone modulation of rat aortic steroid hormone receptors. Endocrinology 1986;119:296-302.
17. Horwitz KB, Horwitz LD. Canine vascular tissues are targets for androgens, estrogens, progestins and glucocorticoids. J Clin Invest 1982;69:750-8.
18. Lin AL, Schultz JJ, Brenner RM, Shain SA. Sexual dimorphism characterizes baboon myocardial androgen receptors but not myocardial estrogen and progesterone receptors. J Steroid Biochem Mol Biol 1990;37:85-95.
19. Campisi E, Cutolo M, Carruba G, et al. Evidence for soluble and nuclear site I binding of estrogens in human aorta. Atherosclerosis 1993;103:267-77.
20. Ingegno MD, Money SR, Thelmo W, et al. Progesterone receptors in the human heart and great vessels. Lab Invest 1988;59:353-6.
21. Quinones-Jenab V, Jenab S, Ogawa S, Adan RAM, Burbach JPH, Pfaff DW. Effects of estrogen on oxytocin receptor messenger ribonucleic acid expression in the uterus, pituitary, and forebrain of the female rat. Mol Neuroendocrinol 1997;65:9-17.
22. Larcher A, Neculcea J, Breton C, et al. Oxytocin receptor gene expression in the rat uterus during pregnancy and the estrous cycle and in response to gonadal steroid treatment. Endocrinology 1995;136:5350-6.
23. Shaw CA, Wilkinson M. Receptor characterization and regulation in intact tissue preparations. Biochem Pharmacol 1994;47:1109-19.
24. 3H]DAGO) binding sites in rat hypothalamus and ex vivo determination of blood-brain barrier penetration by opioid peptide FK 33-824. Dev Brain Res 1990;54:169-76.
25. Watson-Wright WM, Wilkinson M. The muscle slice - a new preparation for the characterization of β-adrenergic binding in fast- and slow-twitch skeletal muscle. Muscle Nerve 1986;9:416-22.
26. Van Huizen F, Shaw C, Wilkinson M, Cynader M. Characterization of muscarinic acetylcholine receptors in rat cerebral cortex slices with concomitant morphological and physiological assessment of tissue viability. Mol Brain Res 1989;5:59-69.
27. Wilkinson M, MacDonald MC, Landymore K, Wilkinson D. Opioid receptors in micropunches of fresh hypothalamic tissue: a binding assay for Everyman. In: Greenstein B, ed. Neuroendocrine Research Methods. London: Harwood, 1991:723-46.
28. 3H] N-methyl scopolamine) binding in micropunches of rat ventricular myocardium: characterization and modification by progesterone. Can J Physiol Pharmacol 1992;70:943-8.
29. 2 muscarinic receptor binding by progesterone-related steroids. J Mol Cell Cardiol 1995;27:1831-9.
30. 3H]CGP-12177) binding in myocardial slices of cardiomyopathic hamsters. Can J Cardiol 1989;5:175-80.
31. Goodwin TM, Valenzuela GJ, Silver H, Creasy G. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group. Obstet Gynecol 1996;88:331-6.
32. Nathanielsz PW, Honnebier MB, Mecenas C, Jenkins SL, Holland ML, Demarest K. Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturnal myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygenation in the pregnant baboon during the last third of gestation. Biol Reprod 1997;57:320-4.
33. Greig PC, Massman GA, Figueroa JP. Maternal and fetal cardiovascular effects of the oxytocin antagonist (OTA) Atosiban on late gestation pregnant sheep. Am J Obstet Gynecol 1993;168:335. (Abst 129)
34. Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann SM. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci USA 1997;94:11704-9.
35. Tribollet E, Audigier S, Dubois-Dauphin M, Dreifuss JJ. Gonadal steroids regulate oxytocin receptors but not vasopressin receptors in the brain of male and female rats. An autoradiographical study. Brain Res 1990;511:129-40.
36. Fang X, Wong S, Mitchell BF. Effects of RU486 on estrogen, progesterone, oxytocin and their receptors in the rat uterus during late pregnancy. Endocrinology 1997;138:2763-8.
37. Dawood MY, Ylikorkala O, Trivedi D, Fuchs F. Oxytocin in maternal circulation and amniotic fluid during pregnancy. J Clin Endocrinol Metab 1979;49:429-34.
38. Swans LW, McKellar S. The distribution of oxytocin and neurophysin-stained fibres in the spinal cord of the rat and monkey. J Comp Neurol 1979;188:87-106.
39. Petty MA, Lang RE, Unger T, Ganten D. The cardiovascular effects of oxytocin in conscious male rats. Eur J Pharmacol 1985;112:203-10.
40. Jansen ASP, Wessendorf MW, Loewy AD. Transneuronal labeling of CNS neuropeptide and monoamine neurons after pseudorabies virus injections into the stellate ganglion. Brain Res 1995;683:1-24.
41. Altura BM. Humoral, hormonal, and myogenic mechanisms in microcirculatory regulation. In: Kaley G, Altura BM, eds. Microcirculation, vol II. Baltimore: University Park Press, 1978:431-502.
42. Abrams GM, Nilaver G, Recht LR, et al. Hypothalamic oxytocin: a cerebrovascular modulator in man? Neurology 1985;35:1046-9.
43. Coulson CC, Thorp JM, Mayer DC, Cefalo RC. Central hemodynamic effects of recombinant human relaxin in the isolated, perfused rat heart model. Obstet Gynecol 1996;87:610-2.